Phase II Study of Gemcitabine, Carboplatin, and Iniparib As Neoadjuvant Therapy for Triple-Negative and BRCA1/2 Mutation-Associated Breast Cancer With Assessment of a Tumor-Based Measure of Genomic Instability: PrECOG 0105.
J Clin Oncol
; 33(17): 1895-901, 2015 Jun 10.
Article
en En
| MEDLINE
| ID: mdl-25847929
Texto completo:
1
Bases de datos:
MEDLINE
Asunto principal:
Mastectomía Segmentaria
/
Protocolos de Quimioterapia Combinada Antineoplásica
/
Proteína BRCA1
/
Terapia Neoadyuvante
/
Proteína BRCA2
/
Inestabilidad Genómica
/
Neoplasias de la Mama Triple Negativas
Tipo de estudio:
Guideline
/
Prognostic_studies
/
Risk_factors_studies
/
Systematic_reviews
Límite:
Adult
/
Aged
/
Female
/
Humans
/
Middle aged
Idioma:
En
Revista:
J Clin Oncol
Año:
2015
Tipo del documento:
Article